Results for tag: "Oncaspar"

Oncaspar is a market of drugs used to treat acute lymphoblastic leukemia (ALL). It is a type of chemotherapy drug that works by targeting and destroying cancer cells. Oncaspar is a recombinant form of the naturally occurring enzyme asparaginase, which is used to break down the amino acid asparagine, which is essential for the growth of cancer cells. Oncaspar is used in combination with other chemotherapy drugs to treat ALL. It is also used to treat other types of leukemia, such as chronic myeloid leukemia (CML). Oncaspar is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2014. It is used in combination with other chemotherapy drugs to treat ALL, and is generally well-tolerated by patients. The Oncaspar market is highly competitive, with several major pharmaceutical companies competing for market share. Some of the companies in the market include Pfizer, Novartis, Merck, and Bristol-Myers Squibb. Show Less Read more